Canada-based Psyence Biomed has completed a merger with Newcourt Acquisition Corp. (NASDAQ: NCAC), making the palliative care-focused psychedelics company publicly traded in the United States. Psyence Biomed is a subsidiary of the Canadian biotech company Psyence Group Inc. Psyence is publicly traded on the Canadian Securities Exchange and has made natural psychedelic products the focus […]
Newcourt Acquisition Corp.
A new, publicly traded company devoted to exploring the use of psychedelics in palliative care is in development. Psyence Biomed, a subsidiary of the Canadian biotech company Psyence Group Inc., has signed a definitive business combination agreement with Newcourt Acquisition Corp. (NASDAQ: NCAC) to create the new organization. Psyence Biomed expects to receive a minimum […]